HIF1A and breast cancer: The primary endothelial response that initiates angiogenic hypoxia signaling in breast cancer and particularly activates tumor-associated macrophages (TAMs) to produce pro-angiogenic cytokines and growth factors involves stable HIF-1α expression [105, 106].